Synapse Biomedical Inc. Receives CE Approval for TransAeris, the First Medical Device Approved for the Treatment of Ventilator Induced Diaphragm Dysfunction (VIDD)
Synapse Biomedical (www.synapsebiomedical.com), an innovator in neurostimulation and manufacturer of the NeuRx Diaphragm Pacing System®, announced today, the CE Mark approval for the TransAeris™ System. TransAeris is a temporary diaphragm stimulator, for use in intensive care unit (ICU) patients on mechanical ventilation (MV). While MV provides life sustaining respiration, side effects of prolonged MV include diaphragm atrophy and dysfunction, which is referred to as ventilator-induced diaphragm dysfunction (VIDD). A primary contributor to extending ICU ventilator weaning times, VIDD increases health care costs and greatly increases patient morbidity and mortality. Building on more than 25 years of diaphragm pacing research and practical experience with their respiratory assist device for Spinal Cord Injury & Lou Gehrig’s Disease SCI & ALS, Synapse is pleased to introduce the TransAeris device, which is now available in Europe and select international markets. “We are excited to leverage our use of the NeuRx platform, and experience with thousands of patients, to this new group of ICU patients. This is the first device to treat VIDD and with TransAeris we hope to help many patients avoid the costs and complications that come with prolonged mechanical ventilation,” said Anthony R. Ignagni, President & CEO of Synapse.
About TransAeris technology
The TransAeris™ System is a temporary percutaneous intramuscular diaphragm stimulator intended for patients at risk of or on prolonged positive pressure mechanical ventilation. TransAeris is indicated for use in the prevention and treatment of ventilator-induced diaphragm dysfunction (VIDD). TransAeris is used to provide neuromuscular electrical stimulation to the diaphragm while the patient is on mechanical ventilation to prevent, slow, or reverse diaphragm disuse atrophy and, more generally, to treat VIDD. Once the patient is successfully extubated after mechanical ventilation, the electrodes are removed from the patient.
About Synapse Biomedical, Inc.
Founded in 2002, Synapse Biomedical's mission is to provide life transforming treatments through the commercialization of neurostimulation platforms and build a sustainable enterprise on the foundation of scientific & clinical findings that will provide meaningful value to patients, employees, community, and shareholders. Synapse is headquartered in Oberlin, Ohio and has a European Office in Enghien les Bains, France. For more information please visit www.synapsebiomedical.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: http://www.businesswire.com/news/home/20180108005174/en/
Contact information
Synapse Biomedical Europe
Moustapha Diop, +33 (0)6 11 67 53 46
COO
& Managing Director
mdiop@synapsebiomedical.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Varian Announces CE Mark for Embozene in Genicular Artery Embolisation, Expanding Treatment for Knee Osteoarthritis9.9.2025 10:00:00 EEST | Press release
Varian, a Siemens Healthineers company, announced today that its Embozene microspheres have received CE Marking for Genicular Artery Embolisation (GAE) for knee osteoarthritis. This regulatory milestone makes Embozene the first—and only—embolic agent to be CE Marked specifically for GAE, a minimally invasive procedure intended to target inflammation and help relieve pain in patients with knee osteoarthritis. Knee osteoarthritis is widespread, with a reported prevalence of nearly 375 million cases globally¹ and can significantly impair physical function and quality of life. While current treatments – such as physical therapy, medications, and intra-articular injections – offer temporary relief, many patients are not yet ready for, or wish to delay, total knee replacement surgery. This gap in care highlights the need for new options that can help patients manage pain and maintain function. GAE is designed to help fill that gap. The procedure involves advancing a small catheter into the g
Ant International’s Bettr Lending Empowers SMEs on Global E-Commerce Platforms as Year-End Shopping Sprees Near9.9.2025 09:31:00 EEST | Press release
Bettr, a leading provider of embedded financing and tech solutions under Ant International, today announced the launch of its AI-driven accounts receivable financing solution designed to provide global e-commerce platform vendors with rapid and secure access to working capital as they prepare for the year-end shopping sprees. Bettr’s solution directly addresses a critical pain point for online vendors on global e-commerce platforms: the need for fast, flexible, and reliable funding to manage increased inventory, marketing spends, and operational costs during the busiest retail period of the year. It leverages advanced AI and machine learning to deliver a seamless experience. “Our goal is to give the vendors the financial agility they need to capitalize on a massive opportunity,” said Quan Yu, General Manager of Credit Services, Ant International. “By integrating our alternative data-powered credit assessment and risk management directly into the e-commerce ecosystem, we can quickly app
LAGENIO Unveils Next-Gen AI-Powered Kids Smartwatch with Simcard at IFA 20259.9.2025 09:07:00 EEST | Press release
LAGENIO, a global leader in kid’s smartwatches, is set to debut its next-generation innovation at IFA 2025 in Berlin, Germany, Booth NO: H27h-12. LAGENIO has unveiled two new models for Europe market: the K9, a premium AI-powered watch phone, and the K3, a creative entry-level model. Designed as a safe first phone alternative for children ages 4 to 12, both devices combine secure communication and parental controls with features that encourage physical activity and healthy digital habits. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250905079305/en/ LAGENIO kids smartwatches in colorful designs with fun cartoon watch faces, fitness tracking, safety features, and educational functions “Parents want to give their kids independence without compromising safety, and kids want technology that feels exciting and fun,” said Li Leung, CEO of LAGENIO. “With the new LAGENIO platform, we have combined performance, design, and child-fr
Nikkiso Addresses Growing Ammonia-Handling Demand and Launches Next-Generation Pump at Gastech 20259.9.2025 09:00:00 EEST | Press release
Nikkiso Clean Energy & Industrial Gases Group (Nikkiso CE&IG) has announced at the Gastech Conference today that it has launched a next-generation submerged ammonia pump designed to be the safest and most reliable in the industry. Ammonia is already a key component in fertilizers and increasingly being used as a clean hydrogen carrier. As demand for handling ammonia has also grown in sectors like power generation, chemical plants, shipping fleets and export terminals, Nikkiso CE&IG has responded with a first-of-its-kind solution designed to eliminate common maintenance burdens for operators thanks to its seal-less, maintenance-friendly, copper-free construction and integrated motor-pump system. The pump is capable of delivering more than 2,500m3 per hour and has an industry-leading maintenance record – specifically-designed parts mean the pump lasts significantly longer before any maintenance requirements, with a mean time between outages topping 16,000 hours. Emile Bado, President of
De’Longhi Launches the Perfetto 3.0 Global Campaign Starring Brad Pitt to Solidify Its Worldwide Coffee Leadership8.9.2025 20:43:00 EEST | Press release
De’Longhi has launched its third global campaign centered on the world of coffee on the occasion of the 82nd Venice Film Festival, where the brand is a supporter and present with special activations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908690655/en/ Brad drinking coffee The new campaign reflects De’Longhi’s continued evolution into alifestyle brand rooted in Italian design and innovation. This 3rd chapter builds upon a proven track record from recent years, which has supported the Group in growing the business and solidifying its market leadership. This campaign is set to be the Group's most extensive to date, with significant consumer reach across all traditional, digital, and social media channels, engaging and targeting the broadest possible audience among coffee lovers and prospective consumers to capitalize on increasing espresso coffee penetration and premiumization. In a first-ever collaboration, Brad Pi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom